FdaApplication
NDA 202331
Identifiers
- fda_app_no: NDA202331
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2011-12-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EDARBYCLOR | AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE | EQ 40MG MEDOXOMIL;12.5MG | TABLET;ORAL |
| EDARBYCLOR | AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE | EQ 40MG MEDOXOMIL;25MG | TABLET;ORAL |
2 products